Order Article Reprints

Clark KC, Hewett DR, Panagopoulos V, Plakhova N, Opperman KS, Bradey AL, Mrozik KM, Vandyke K, Mukherjee S, Davies GCG, et al. Targeted Disruption of Bone Marrow Stromal Cell-Derived Gremlin1 Limits Multiple Myeloma Disease Progression In Vivo. Cancers. 2020; 12(8):2149. https://doi.org/10.3390/cancers12082149

Clark, Kimberley C., Duncan R. Hewett, Vasilios Panagopoulos, Natalya Plakhova, Khatora S. Opperman, Alanah L. Bradey, Krzysztof M. Mrozik, Kate Vandyke, Siddhartha Mukherjee, Gareth C.G. Davies, and et al. 2020. "Targeted Disruption of Bone Marrow Stromal Cell-Derived Gremlin1 Limits Multiple Myeloma Disease Progression In Vivo" Cancers 12, no. 8: 2149. https://doi.org/10.3390/cancers12082149

Clark, K. C., Hewett, D. R., Panagopoulos, V., Plakhova, N., Opperman, K. S., Bradey, A. L., Mrozik, K. M., Vandyke, K., Mukherjee, S., Davies, G. C. G., Worthley, D. L., & Zannettino, A. C. W. (2020). Targeted Disruption of Bone Marrow Stromal Cell-Derived Gremlin1 Limits Multiple Myeloma Disease Progression In Vivo. Cancers, 12(8), 2149. https://doi.org/10.3390/cancers12082149